摘要
卵巢癌是发病率位居第2的女性生殖系统恶性肿瘤,其病死率却高居首位。美国近10年来的流行病学统计数据显示,卵巢癌的发病人数及死亡人数均大致呈上升趋势,2009年的新发病例达到21500例,为近年之最[1]。随着新的诊疗手段及早期诊断的推行,卵巢癌的病死率略有下降,然而与乳腺癌及宫颈癌相比。
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
2011年第10期789-791,共3页
Chinese Journal of Obstetrics and Gynecology
参考文献23
-
1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin,2009,59:225-249.
-
2Singer G, Kurman R J, Chang HW, et al. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol, 2002, 160 : 1223-1228.
-
3Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol,2004,164 : 1511-1518.
-
4Malpica A, Deavers MT, Tornos C, et al. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma. Am J Surg Pathol,2007,31 : 1168-1174.
-
5FIGO Cancer Committee. Staging Announcement. West Berlin. 1985. Gvnecol Oncol. 1986.25:383.
-
6林洁,杜娟,张春妤,谢巧婷,张波,刘从容.卵巢浆液性癌两级组织学分级系统的评估及p53蛋白过表达的意义[J].中华病理学杂志,2010,39(10):655-660. 被引量:21
-
7Plaxe SC. Epidemiology of low-grade serous ovarian cancer. Am J Obstet Gyneco1,2008 ,198 :459.
-
8May T, Virtanen C, Sharma M, et al. Low malignant potential tumors with micropapillary features are molecularly similar to low- grade serous carcinoma of the ovary. Gynecol Oncol,2010,117:9- 17.
-
9Cho YH, Kim DY, Kim JH, et al. Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women. Yonsei Med J,2009,50:266-272.
-
10Schlosshauer PW, Deligdisch L, Penault-Llorca F, et al. Loss of pl6INK4A expression in low-grade ovarian serous carcinomas. Int J Gynecol Pathol,2011,30 :22-29.
二级参考文献18
-
1Shih IM,Kurman RJ.Ovarian tumorigenesis:a proposed model based on morphological and molecular genetic analysis.Am J Pathol,2004,164(5):1511-1518.
-
2Gilks CB,Prat J.Ovarian carcinoma pathology and genetics:recent advances.Hum Pathol,2009,40 (9):1213-1223.
-
3Malpica A,Deavers MT,Lu K,et al.Grading ovarian serous carcinoma using a two-tier system.Am J Surg Pathol,2004,28(4):496-504.
-
4Scully RE.World Health Organization classification and nomenclature of ovarian cancer.Natl Cancer Inst Monogr,1975,42:5-7.
-
5Armstrong DK.Relapsed ovarian cancer:challenges and management strategies for a chronic disease.Oncologist,2002,7 Suppl 5:20-28.
-
6Rustin GJ,Nelstrop AE,Tuxen MK,et al.Defining progression of ovarian carcinoma during follow-up according to CA 125:a North Thames Ovary Group Study.Ann Oncol,1996,7(4):361-364.
-
7Rustin GJ,Nelstrop AE,Crawford M,et al.Phase Ⅱ trial of oral altretamine for relapsed ovarian carcinoma:evaluation of defining response by serum CA125.J Clin Oncol,1997,15 (1):172-176.
-
8Hill DA,Chiosea S,Jamaluddin S,et al.Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme.J Cell Sci,2004,117 (Pt24):5847-5854.
-
9Gilks CB,Vanderhyden BC,Zhu S,et al.Distinction between serous tumors of low malignant potential and serous caroinonas based on global mRNA expression profiling.Gynecol Oncol,2005,96(3):684-694.
-
10Meinhold-Heerlein I,Bauerschlag D,Hilpert F,et al.Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.Oncogene,2005,24 (6):1053-1065.
共引文献20
-
1沈旭霞,喻林,毕蕊,杨文涛.卵巢低、高级别浆液性癌的临床病理分析及Pax2、p53和Ki-67表达的意义[J].中华病理学杂志,2011,40(8):511-516. 被引量:18
-
2孔北华,Wen-xin ZHENG.重视卵巢癌的二元论模型与卵巢外起源新说[J].中华妇产科杂志,2011,46(10):721-723. 被引量:17
-
3赵立武,申彦,师宜荃,刘艳,刘易欣.P16 P53 CyclinD1在卵巢浆液性癌中的表达及意义[J].中国肿瘤临床,2012,29(7):388-391. 被引量:2
-
4赵立武,申彦,师宜荃,刘艳,刘易欣.P16、P53和CyclinD1蛋白在卵巢浆液性肿瘤中的表达及意义[J].解剖学研究,2012,34(4):251-255. 被引量:6
-
5刘冲,郭庆,石群立,余波,马恒辉,刘琦.PAX2在卵巢浆液性腺癌中的表达及在MDACC分级系统中的应用价值[J].诊断病理学杂志,2012,19(4):298-301. 被引量:4
-
6戴敏,赵迎春.低级别、高级别卵巢浆液性癌临床病理分析及CA125、p53和Ki-67表达的意义[J].中国肿瘤,2012,21(8):631-634. 被引量:3
-
7陈丽倩,林洁,席晨光,刘从容.不同级别卵巢浆液性癌中E-cadherin和p120蛋白的表达及意义[J].现代妇产科进展,2012,21(8):585-589. 被引量:2
-
8李艳芳,李荣霞,史淑红.上皮性卵巢癌细胞起源新学说[J].现代妇产科进展,2013,22(2):152-153. 被引量:1
-
9汪向明,张帆,顾倩,马少平.卵巢浆液性癌病理发病机制研究进展[J].中国实用妇科与产科杂志,2013,29(3):236-240. 被引量:9
-
10王仁杰,熊丽芳,胡文娟,吴颖虹,刘小景.PAX2及PAX8在卵巢浆液性腺癌中的表达及其临床意义[J].长江大学学报(自科版)(下旬),2013,9(12):22-23. 被引量:3
同被引文献112
-
1杨晓东,李雅华,张丽莉.复发性卵巢癌的综合治疗[J].中国肿瘤临床与康复,2007,14(2):173-177. 被引量:8
-
2乐杰.妇产科学[M].6版.北京:人民卫生出版社,2009:125.
-
3Kriebs JM, Fahey JO. Ectopic pregnancy [J]. Midwifery Womens Health, 2006, 51(6): 431.
-
4Yao M, Tulandi T. Current status of surgical and nonsurgical management of ectopic pregnancy[J]. Fertil Steril, 1997, 67(3) : 421.
-
5Li J, Abushahin N, Pang S, et al. Tubal origin of ' ovarian' low-grade serous carinoma [EB/OL]. [2011-08-201. http ://www. nature, com/ modpathol/journal/vaop/ncurrent/full/modpathol2011106a, html.
-
6Salvador S, Gilks B, Kobel M, et al. The fallopian tube : primary site of most pelvic high-grade serous carcinomas [J]. Int J Gynecol Cancer, 2009,19( 1 ) :58-64.
-
7Shih IM,Kurman RJ. Ovarian tumorigenesis:a proposed model based on morphological and molecular genetic analysis[J].American Journal of Pathology,2004,(05):1511-1518.
-
8Wong AS,Leung PC. Role of endocrine and growth factors on the ovarian surface epithelium[J].Journal of Obstetrics and Gynaecology Research,2007,(01):3-16.
-
9Kindelberger DW,Lee Y,Miron A. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma:Evidence for a causal relationship[J].American Journal of Surgical Pathology,2007,(02):161-169.
-
10Lee Y,Miron A,Drapkin R. A candidate precursor to serous carcinoma that originates in the distal fallopian tube[J].Journal of Pathology,2007,(01):26-35.doi:10.1002/path.2091.
引证文献10
-
1程一姗,孔红霞,杨立.输卵管结扎对卵巢癌影响的临床分析[J].中国实用医刊,2013,40(5):53-55. 被引量:8
-
2封全灵,丁俊珊,李秋芳,刘弘扬,王红丽.腹腔镜两种术式治疗输卵管壶腹部妊娠临床分析[J].中国实用医刊,2014,41(10):45-47. 被引量:5
-
3陈惠梅,蒙丽萍,张桂彩,池琳琳,吴忠旺.卵巢癌患者围手术期人性化护理的效果评价[J].中国肿瘤临床与康复,2014,21(5):626-628. 被引量:4
-
4董春红,纪建红,王瑶康.51例卵巢癌患者围术期护理[J].中国实用医药,2015,10(14):241-242. 被引量:1
-
5王冠.合并内科疾病的妇科患者职业类型与疾病的相互关系分析[J].河北医药,2015,37(13):2047-2048.
-
6付冲,胡建国.c-cbl基因沉默对卵巢癌SKOV3细胞增殖和侵袭的影响[J].重庆医学,2015,44(36):5061-5064. 被引量:2
-
7龙映妃,唐均英.FUNDC1基因沉默对卵巢癌SKOV3细胞增殖和侵袭的影响[J].上海交通大学学报(医学版),2016,36(2):218-223. 被引量:6
-
8李明霞,魏丽惠.输卵管结扎对子宫内膜癌及卵巢上皮性癌影响的研究进展[J].中华妇产科杂志,2016,51(9):718-720. 被引量:1
-
9朱亚飞,张文书,叶萍,康川川,何华.HE4和CA125在高、低级别浆液性卵巢癌中表达差异的对照研究[J].赣南医学院学报,2018,38(1):11-15. 被引量:2
-
10刘晓英,甘露,张静,姚蕾,邓卓.卵巢癌组织中Ezrin、SP1蛋白的表达及与肿瘤发生发展的关系[J].标记免疫分析与临床,2019,26(10):1659-1662. 被引量:1
二级引证文献30
-
1杨立,张颖,赵倩,程一姗,王冰冰,袁晓瑞.输卵管结扎对卵巢癌影响的研究[J].现代妇产科进展,2013,22(12):983-985. 被引量:1
-
2韦滟玟.卵巢浆液性癌病理发病机制研究进展[J].中国民族民间医药,2014,23(8):51-52. 被引量:1
-
3宋芷霜,郭宝芝,刘爱珍.不同腹腔镜术式对输卵管壶腹部妊娠术后累积妊娠率影响[J].中外医疗,2014,33(33):94-95. 被引量:7
-
4屈巧俊,李燕,土增荣.卵巢癌高危因素研究进展[J].山西医药杂志,2015,44(15):1769-1772. 被引量:4
-
5蔡怡园.输卵管结扎对卵巢癌患者的影响[J].中国实用医刊,2015,42(19):114-115.
-
6崔立新,张洲.宫腹腔镜联合治疗输卵管性不孕症对于妊娠与性生活质量的影响[J].中国性科学,2015,24(9):80-83. 被引量:7
-
7张伟,刘文静,陈琳琳.输卵管结扎时间对卵巢癌发生的临床影响[J].中国肿瘤临床与康复,2016,23(2):182-184. 被引量:1
-
8卢明玥,游存厚,班宁元.异位妊娠治疗的研究进展[J].内蒙古医学杂志,2016,48(2):175-177. 被引量:7
-
9孙海燕.人性化护理在卵巢肿瘤患者护理中的应用[J].中西医结合护理(中英文),2015,1(2):42-43. 被引量:7
-
10石利香.对卵巢癌患者进行延续护理的效果探析[J].当代医药论丛,2016,14(14):149-151. 被引量:2
-
1刘旭斌,邹汉良,余德奎,陶绪雄,杨娟.肝细胞癌患者血清let-7a、let-7f表达水平及其临床意义[J].肝脏,2015,20(9):733-735. 被引量:6
-
2李杰,王立杰,相丽,孔北华,Wen-xin ZHENG.卵巢癌的二元论模型及细胞起源与发病机制[J].中华妇产科杂志,2011,46(10):792-795. 被引量:4
-
3姚爱琳,刘国艳,糜若然.卵巢交界性肿瘤的研究进展[J].国外医学(妇产科学分册),2004,31(1):44-46. 被引量:6
-
4郭艳萍,赵静.上皮性卵巢癌的研究进展[J].临床合理用药杂志,2015,8(2):178-179. 被引量:8
-
5孔北华,Wen-xin ZHENG.重视卵巢癌的二元论模型与卵巢外起源新说[J].中华妇产科杂志,2011,46(10):721-723. 被引量:17
-
6段瑞岐,郄明蓉.p53基因突变与上皮性卵巢癌发病分型关系初探[J].华西医学,2016,31(8):1389-1393.
-
7张双革.人附睾蛋白4与癌抗原125在卵巢癌二元论模型中的应用[J].国际妇产科学杂志,2014,41(3):285-289. 被引量:3
-
8张会来,王华庆.紫杉醇联合FP方案治疗70岁以上老年晚期胃癌研究[J].天津医药,2006,34(5):339-340.
-
9王小兰.二元论下卵巢透明细胞癌的再分型[J].现代医学,2015,43(1):122-125. 被引量:1
-
10贺喜武,张强.颅骨骨囊肿1例报道[J].青海医学院学报,2009,30(2):143-143.